N
Neil Benson
Researcher at Pfizer
Publications - 34
Citations - 2205
Neil Benson is an academic researcher from Pfizer. The author has contributed to research in topics: Systems pharmacology & Phosphorylation. The author has an hindex of 16, co-authored 34 publications receiving 2046 citations.
Papers
More filters
Journal ArticleDOI
Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression
David E. Nelson,Adaoha E. C. Ihekwaba,M Elliott,James R. Johnson,C. A. Gibney,B. E. Foreman,Glyn Nelson,Violaine Sée,Caroline A. Horton,David G. Spiller,Steven W. Edwards,H. P. McDowell,John Unitt,Elaine Sullivan,Rachel L. Grimley,Neil Benson,David S. Broomhead,Douglas B. Kell,Michael R. H. White +18 more
TL;DR: Single-cell time-lapse imaging and computational modeling of NF-κB (RelA) localization showed asynchronous oscillations following cell stimulation that decreased in frequency with increased IκBα transcription.
Journal ArticleDOI
Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development.
TL;DR: Application of systems pharmacology can now impact across all stages of drug research and development, and has the potential to become an integral component of a new ‘enhanced quantitative drug discovery and development’ (EQD3) R&D paradigm.
Journal ArticleDOI
Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development
Peter A. Milligan,M.J. Brown,B Marchant,Steven W. Martin,P H van der Graaf,Neil Benson,G Nucci,Don Nichols,Rebecca A. Boyd,J W Mandema,Sriram Krishnaswami,Samuel H. Zwillich,David Gruben,R.J. Anziano,Thomas C. Stock,Richard L. Lalonde +15 more
TL;DR: The role model‐based drug development approaches can and do play in accelerating and optimizing compound development strategies through a series of illustrative examples are discussed.
Journal ArticleDOI
Sensitivity analysis of parameters controlling oscillatory signalling in the NF-/sub K/Bpathway: the roles of IKK and I/sub K/B/sub alpha/
TL;DR: In this article, a model of the nuclear factor, κB (NF-κB) signalling pathway, containing 64 parameters and 26 variables, including steps in which the activation of the NF-κb transcription factor is intimately associated with the phosphorylation and ubiquitination of its inhibitor by a membrane-associated kinase, and its translocation from the cytoplasm to the nucleus.
Journal ArticleDOI
Synergistic control of oscillations in the NF-kappaB signalling pathway.
Adaoha E. C. Ihekwaba,David S. Broomhead,Rachel L. Grimley,Neil Benson,Michael R. H. White,Douglas B. Kell +5 more
TL;DR: Analysis of dynamic models of part of the NF-kappaB signalling pathway reveals a level of complexity in these dynamic models that is not apparent from study of their individual parameters alone and point to the value of manipulating multiple elements of complex networks to achieve desired physiological effects.